{"chebi_id":"4814","chebi_name":"eprosartan","chebi_synonyms":["Eprosartan","(E)-\u03b1{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid","(E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid","4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid","(E)-2-butyl-1-(p-carboxybenzyl)-\u03b1-2-thenylimidazole-5-acrylic acid"],"diffprof_id_observed":["MTBLS2871_0001_00000009"],"diffprof_id_var_observed":[],"inchikey":"OROAFUQRIXKEMV-LDADJPATSA-N","inn_name":"eprosartan","iupac_name":"4-({2-butyl-5-[(1<i>E</i>)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1<em>H</em>-imidazol-1-yl}methyl)benzoic acid","num_study_observed":1,"reactome_ids":["R-HSA-162582","R-HSA-372790","R-HSA-373076","R-HSA-375276","R-HSA-500792"],"reactome_names":["Signal Transduction","Signaling by GPCR","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors","GPCR ligand binding"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":[],"synonym_name":"(<i>E</i>)-3-[2-<em>n</em>-butyl-1-{(4-carboxyphenyl)methyl}-1<em>H</em>-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid"}